Related Experiment Videos
[Platelet aggregation in patients with hypertrophic cardiomyopathy]
Insights
Platelet aggregation increases with left ventricular hypertrophy (LVH) in hypertrophic cardiomyopathy (HC) patients. This study found a direct correlation between heightened platelet activity and the severity of LVH in HC.
Area of Science:
- Cardiology
- Hematology
Background:
- Hypertrophic cardiomyopathy (HC) is a cardiac condition characterized by left ventricular hypertrophy (LVH).
- Platelet aggregation plays a role in cardiovascular disease pathogenesis.
Purpose of the Study:
- To investigate the relationship between platelet aggregation and the extent of LVH in patients diagnosed with HC.
Main Methods:
- Evaluated 45 male HC patients and 15 healthy controls.
- Utilized clinical examination, ECG, echocardiography, platelet aggregation tests, and biochemical blood analyses.
Main Results:
- HC patients exhibited elevated spontaneous and induced platelet aggregation.
- Platelet aggregation levels correlated positively with left ventricular myocardial mass.
- Platelets in LVH patients showed increased sensitivity to U-46619, a thromboxane A2 analogue.
Conclusions:
- A significant positive correlation exists between platelet aggregation and the degree of LVH in individuals with HC.
Aim:
To examine correlation between platelet aggregation and the degree of left ventricular hypertrophy (LVH) in patients with hypertrophic cardiomyopathy (HC).
Material And Methods:
Routine clinical examination, ECG, echo-CG, measurement of platelet aggregation, routine biochemical blood tests were made in 45 HC males and 15 healthy controls.
Results:
HC patients were characterized with high induced and spontaneous platelet aggregation which increased with left ventricular myocardial mass. In LVH, platelets were especially sensitive to the aggregation inductor U-46619, thromboxane A2 analogue.
Conclusion:
It is demonstrated that there is a positive correlation between platelet aggregation and the degree of LVH in HC patients.